Can saxagliptin tablets cause hypoglycemia

In recent years, with the rapid development of biopharmaceutical technology, many new hypoglycemic drugs are more and more concerned and recognized by the majority of diabetes patients! Among them, the dipeptidyl peptidase-4 (DPP-4) inhibitor represented by Lukezuo Shagliptin Tablets (produced by Qilu Pharmaceutical) is recommended by the authoritative diabetes guidelines at home and abroad and recognized by the majority of diabetes patients because of its unique mechanism of action, efficacy determination and other factors! However, many patients with diabetes are also worried about the question, "Will Shagliptin tablets cause hypoglycemia?"?

For the question of whether saxagliptin tablets can cause hypoglycemia, you can keep your heart in your stomach! Compared to other hypoglycemic drugs, the incidence of hypoglycemia in saxagliptin is significantly lower, and saxagliptin tablets generally do not cause hypoglycemia under normal use.

Saxagliptin belongs to the DPP-4 inhibitor class of drugs. DPP-4 inhibitors can inhibit endogenous incretin, such as the inactivation of glucagon like peptide-1 (GLP-1) and glucose dependent insulinotropic protein (GIP), increase the levels of endogenous GLP-1 and GIP, promote the regeneration and release of insulin from pancreatic beta cells, and inhibit the secretion of glucagon by pancreatic alpha cells, thereby increasing insulin levels and lowering blood sugar. Clinical studies have shown that saxagliptin tablets typically do not cause severe hypoglycemic events. This is because the mechanism of action of saxagliptin tablets is glucose dependent glucose lowering, which means that when blood sugar levels rise, it promotes insulin secretion and lowers blood sugar. Therefore, under normal circumstances, the use of saxagliptin tablets does not cause hypoglycemia.

It should be noted that in certain situations, such as when patients use other hypoglycemic drugs (such as sulfonylureas or insulin) at the same time, there may be a risk of hypoglycemia. In addition, if patients do not eat on time or consume insufficient calories, it may also lead to the occurrence of hypoglycemia. Therefore, when taking saxagliptin tablets, patients should follow the doctor's advice and have a reasonable diet!

The above is the answer to the question of "Can saxagliptin tablets cause hypoglycemia?" Compared to traditional hypoglycemic drugs, the safety of Lukozo saxagliptin tablets is trustworthy! In clinic, because of its unique mechanism of action, definite curative effect, low incidence of hypoglycemia, neutral effect on body weight, good cardiovascular safety and other characteristics, it is recommended by authoritative guidelines for diabetes at home and abroad and recognized by more and more diabetes patients, so you can use it with confidence.